Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
National Cancer Institute (NCI) Clinical Trials Information presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance by using a real physician. We are not docs. Always confer with your doctor about National Cancer Institute (NCI) clinical studies. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. National Cancer Institute (NCI) Clinical research trials and National Cancer Institute (NCI) health trials happen in a lot of of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically evaluate the potency of new does drugs. The aim of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies like National Cancer Institute (NCI) to locate treatments for all forms of conditions. National Cancer Institute (NCI) Clinical Trials and other clinical trials allow volunteers to access healthcare treatment alternatives before they are available to the masses. Most times the subjects obtain treatment for free, and sometimes they are paid for their time. Sometimes there is a cost for a National Cancer Institute (NCI) clinical trial. Human subjects typically obtain the finest healthcare available for their condition. Hazards are a reality, nevertheless, and could include more or frequent mD trips, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.

Home > "N" Clinical Trials Sponsors > National Cancer Institute (NCI) Clinical Trials

National Cancer Institute (NCI) Clinical Trials



(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

2-Methoxyestradiol (2-ME2) to Treat Solid Tumor Cancers
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Refractory Hematologic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin with G-CSF for Patients with Newly Diagnosed Advanced Stage Ovarian Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Multicenter, Open, Non-Comparative, Sequential Dose-Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Two Separate Doses of MK-0991 in Children with New Onset Fever and Neutropenia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Multimodality Treatment Approach to Patients with Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children with Leukemia
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children with HIV Infection
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I and Pharmacologic Study of 17-(Allylamino)-17-demethoxygeldanamycin (AAG, NSC 330507) in Adult Patients with Solid Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of 2-Chlorodeoxyadenosine and Radiation for the Treatment of High Grade Glioma (CDX)
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of a Histone Deacetylase Inhibitor, MS-275, with an Oral 28-Day Dosing Schedule in Refractory Solid Tumors and Lymphomas
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Concomitant Therapy with Proteasome Inhibitor PS-341 and Radiation in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients with Metastatic Renal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of gp100 Human Melanoma Peptide Vaccine with Incomplete Freund's Adjuvant
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Infusional Chemotherapy with the P-Glycoprotein Antagonist PSC 833
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Infusional Paclitaxel with the P-Glycoprotein Antagonist PSC 833
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination with Escalating Doses of Ganciclovir in Patients with Cutaneous Metastatic Malignant Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients with Solid Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Isolated Hepatic Perfusion with Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) with Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) with/without Tamoxifen in Patients with Osteosarcoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Recombinant Vaccinia Virus that Expresses Prostate Specific Antigen in Adult Patients with Adenocarcinoma of the Prostate
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of SU101 in Pediatric Patients with Refractory Malignancy
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of the Combination of Continuous Daily CAI and Intermittent Paclitaxel in Adult Patients with Refractory Cancers or Lymphoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Weekly Gemcitabine Given in Combination with Infusional Fluorouracil and Oral and Intravenous Calcium Leucovorin in Adult Cancer Patients
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Weekly Gemcitabine in Combination with Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of 5-Flouroucacil Given with 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients with Solid Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of a CEA-TRICOM Based Vaccine and Radiation to Liver Metastasis with or without cCelecoxib in Patients with CEA Positive Solid Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of Bevacizumab in Refractory Solid Tumors
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of CC-8490 for the Treatment of Patients with Recurrent/Refractory High-Grade Gliomas
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of Continuous Infusion UCN-01 in Patients with Refractory Neoplasms
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of Daily Bolus Flavopiridol in Patients with Refractory Neoplasms
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of Oral Perifosine with Different Loading Schedules in Patients with Refractory Neoplasms
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of Tamoxifen and 9-cis-Retinoic Acid in Breast Cancer Patients
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients with Advanced Neoplastic Disease
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)



National Cancer Institute (NCI) Clinical Trials
Modify your Search

Other "N" Clinical Trials Sponsors:

Nabi Biopharmaceuticals
National Cancer Institute (nci)
National Cancer Institute Of Canada
National Cancer Research Institute (ncri)
National Center For Complementary And Alternative Medicine (nccam)
National Center For Research Resources (ncrr)
National Eye Institute (nei)
National Heart, Lung, And Blood Institute (nhlbi)
National Human Genome Research Institute (nhgri)
National Institute Of Allergy And Infectious Diseases (niaid)
National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams)
National Institute Of Child Health And Human Development (nichd)
National Institute Of Dental And Craniofacial Research (nidcr)
National Institute Of Diabetes And Digestive And Kidney Diseases (niddk)
National Institute Of Environmental Health Sciences (niehs)
National Institute Of Mental Health (nimh)
National Institute Of Neurological Disorders And Stroke (ninds)
National Institute Of Nursing Research (ninr)
National Institute On Aging (nia)
National Institute On Alcohol Abuse And Alcoholism (niaaa)
National Institute On Deafness And Other Communication Disorders (nidcd)
National Institute On Drug Abuse (nida)
National Library Of Medicine (nlm)
National Surgical Adjuvant Breast And Bowel Project (nsabp)
Neopharm
Neorx Corporation
Neotherapeutics
Neurex
Neurochem Inc.
Neurocrine Biosciences
Neurogesx
Neuropace
New Jersey Medical School
New York Gynecological Oncology Group
Newbiotics
Newport Pharmaceuticals International
Nexstar Pharmaceuticals
Nitromed
Nmrc Asia-Pacific Hepatocellular Carcinoma Trials Group
Nmrc Head And Neck Cancer Group
Nmrc International Colorectal Cancer Trials Group
Nmrc Nasopharyngeal Cancer Work Group
Nordic Society For Gynaecologic Oncology
Norris Cotton Cancer Center
North American Brain Tumor Consortium
North Central Cancer Treatment Group
Northfield Laboratories
Northwest Biotherapeutics
Northwestern Memorial Hospital
Northwestern University
Novacea
Novartis Pharmaceuticals
Novo Nordisk Pharmaceuticals
Novogen
Novum
Novuspharma
Nps Allelix Corp.
Nucryst Pharmaceuticals
Nuvelo


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103